2024-05-012025-04-302025-04-30false10141193THE BOSTON BLADE LIMITED2025-12-2396020falseiso4217:GBPxbrli:pure101411932024-04-30101411932025-04-30101411932024-05-012025-04-30101411932023-04-30101411932024-04-30101411932023-05-012024-04-3010141193bus:SmallEntities2024-05-012025-04-3010141193bus:AuditExempt-NoAccountantsReport2024-05-012025-04-3010141193bus:FullAccounts2024-05-012025-04-3010141193bus:PrivateLimitedCompanyLtd2024-05-012025-04-3010141193core:WithinOneYear2025-04-3010141193core:AfterOneYear2025-04-3010141193core:WithinOneYear2024-04-3010141193core:AfterOneYear2024-04-3010141193core:ShareCapital2025-04-3010141193core:SharePremium2025-04-3010141193core:RevaluationReserve2025-04-3010141193core:OtherReservesSubtotal2025-04-3010141193core:RetainedEarningsAccumulatedLosses2025-04-3010141193core:ShareCapital2024-04-3010141193core:SharePremium2024-04-3010141193core:RevaluationReserve2024-04-3010141193core:OtherReservesSubtotal2024-04-3010141193core:RetainedEarningsAccumulatedLosses2024-04-3010141193core:LandBuildings2025-04-3010141193core:PlantMachinery2025-04-3010141193core:Vehicles2025-04-3010141193core:FurnitureFittings2025-04-3010141193core:OfficeEquipment2025-04-3010141193core:NetGoodwill2025-04-3010141193core:IntangibleAssetsOtherThanGoodwill2025-04-3010141193core:ListedExchangeTraded2025-04-3010141193core:UnlistedNon-exchangeTraded2025-04-3010141193core:LandBuildings2024-04-3010141193core:PlantMachinery2024-04-3010141193core:Vehicles2024-04-3010141193core:FurnitureFittings2024-04-3010141193core:OfficeEquipment2024-04-3010141193core:NetGoodwill2024-04-3010141193core:IntangibleAssetsOtherThanGoodwill2024-04-3010141193core:ListedExchangeTraded2024-04-3010141193core:UnlistedNon-exchangeTraded2024-04-3010141193core:LandBuildings2024-05-012025-04-3010141193core:PlantMachinery2024-05-012025-04-3010141193core:Vehicles2024-05-012025-04-3010141193core:FurnitureFittings2024-05-012025-04-3010141193core:OfficeEquipment2024-05-012025-04-3010141193core:NetGoodwill2024-05-012025-04-3010141193core:IntangibleAssetsOtherThanGoodwill2024-05-012025-04-3010141193core:ListedExchangeTraded2024-05-012025-04-3010141193core:UnlistedNon-exchangeTraded2024-05-012025-04-3010141193core:MoreThanFiveYears2024-05-012025-04-3010141193core:Non-currentFinancialInstruments2025-04-3010141193core:Non-currentFinancialInstruments2024-04-3010141193dpl:CostSales2024-05-012025-04-3010141193dpl:DistributionCosts2024-05-012025-04-3010141193core:LandBuildings2024-05-012025-04-3010141193core:PlantMachinery2024-05-012025-04-3010141193core:Vehicles2024-05-012025-04-3010141193core:FurnitureFittings2024-05-012025-04-3010141193core:OfficeEquipment2024-05-012025-04-3010141193dpl:AdministrativeExpenses2024-05-012025-04-3010141193core:NetGoodwill2024-05-012025-04-3010141193core:IntangibleAssetsOtherThanGoodwill2024-05-012025-04-3010141193dpl:GroupUndertakings2024-05-012025-04-3010141193dpl:ParticipatingInterests2024-05-012025-04-3010141193dpl:GroupUndertakingscore:ListedExchangeTraded2024-05-012025-04-3010141193core:ListedExchangeTraded2024-05-012025-04-3010141193dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-05-012025-04-3010141193core:UnlistedNon-exchangeTraded2024-05-012025-04-3010141193dpl:CostSales2023-05-012024-04-3010141193dpl:DistributionCosts2023-05-012024-04-3010141193core:LandBuildings2023-05-012024-04-3010141193core:PlantMachinery2023-05-012024-04-3010141193core:Vehicles2023-05-012024-04-3010141193core:FurnitureFittings2023-05-012024-04-3010141193core:OfficeEquipment2023-05-012024-04-3010141193dpl:AdministrativeExpenses2023-05-012024-04-3010141193core:NetGoodwill2023-05-012024-04-3010141193core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3010141193dpl:GroupUndertakings2023-05-012024-04-3010141193dpl:ParticipatingInterests2023-05-012024-04-3010141193dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3010141193core:ListedExchangeTraded2023-05-012024-04-3010141193dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3010141193core:UnlistedNon-exchangeTraded2023-05-012024-04-3010141193core:NetGoodwill2025-04-3010141193core:IntangibleAssetsOtherThanGoodwill2025-04-3010141193core:LandBuildings2025-04-3010141193core:PlantMachinery2025-04-3010141193core:Vehicles2025-04-3010141193core:FurnitureFittings2025-04-3010141193core:OfficeEquipment2025-04-3010141193core:AfterOneYear2025-04-3010141193core:WithinOneYear2025-04-3010141193core:ListedExchangeTraded2025-04-3010141193core:UnlistedNon-exchangeTraded2025-04-3010141193core:ShareCapital2025-04-3010141193core:SharePremium2025-04-3010141193core:RevaluationReserve2025-04-3010141193core:OtherReservesSubtotal2025-04-3010141193core:RetainedEarningsAccumulatedLosses2025-04-3010141193core:NetGoodwill2024-04-3010141193core:IntangibleAssetsOtherThanGoodwill2024-04-3010141193core:LandBuildings2024-04-3010141193core:PlantMachinery2024-04-3010141193core:Vehicles2024-04-3010141193core:FurnitureFittings2024-04-3010141193core:OfficeEquipment2024-04-3010141193core:AfterOneYear2024-04-3010141193core:WithinOneYear2024-04-3010141193core:ListedExchangeTraded2024-04-3010141193core:UnlistedNon-exchangeTraded2024-04-3010141193core:ShareCapital2024-04-3010141193core:SharePremium2024-04-3010141193core:RevaluationReserve2024-04-3010141193core:OtherReservesSubtotal2024-04-3010141193core:RetainedEarningsAccumulatedLosses2024-04-3010141193core:NetGoodwill2023-04-3010141193core:IntangibleAssetsOtherThanGoodwill2023-04-3010141193core:LandBuildings2023-04-3010141193core:PlantMachinery2023-04-3010141193core:Vehicles2023-04-3010141193core:FurnitureFittings2023-04-3010141193core:OfficeEquipment2023-04-3010141193core:AfterOneYear2023-04-3010141193core:WithinOneYear2023-04-3010141193core:ListedExchangeTraded2023-04-3010141193core:UnlistedNon-exchangeTraded2023-04-3010141193core:ShareCapital2023-04-3010141193core:SharePremium2023-04-3010141193core:RevaluationReserve2023-04-3010141193core:OtherReservesSubtotal2023-04-3010141193core:RetainedEarningsAccumulatedLosses2023-04-3010141193core:AfterOneYear2024-05-012025-04-3010141193core:WithinOneYear2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:CostValuation2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-012025-04-3010141193core:Non-currentFinancialInstrumentscore:CostValuation2025-04-3010141193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-3010141193core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3010141193core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3010141193core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3010141193bus:Director12024-05-012025-04-3010141193core:FurnitureFittingsToolsEquipment2024-04-3010141193core:FurnitureFittingsToolsEquipment2025-04-3010141193core:FurnitureFittingsToolsEquipment2024-05-012025-04-30

THE BOSTON BLADE LIMITED

Registered Number
10141193
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2025

THE BOSTON BLADE LIMITED
Company Information
for the year from 1 May 2024 to 30 April 2025

Director

Mr J Beanland

Registered Address

Old Town Hall
Market Place
Warminster
BA12 9AP

Registered Number

10141193 (England and Wales)
THE BOSTON BLADE LIMITED
Balance Sheet as at
30 April 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets32,5573,008
2,5573,008
Current assets
Debtors4303824
Cash at bank and on hand12,0286,535
12,3317,359
Creditors amounts falling due within one year5(11,398)(5,844)
Net current assets (liabilities)9331,515
Total assets less current liabilities3,4904,523
Creditors amounts falling due after one year6(876)(2,976)
Accruals and deferred income(1,240)(1,240)
Net assets1,374307
Capital and reserves
Called up share capital11
Profit and loss account1,373306
Shareholders' funds1,374307
The financial statements were approved and authorised for issue by the Director on 23 December 2025, and are signed on its behalf by:
Mr J Beanland
Director
Registered Company No. 10141193
THE BOSTON BLADE LIMITED
Notes to the Financial Statements
for the year ended 30 April 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Revenue from sale of goods
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. The company recognizes revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings15
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Fixtures & fittings

Total

££
Cost or valuation
At 01 May 244,8784,878
At 30 April 254,8784,878
Depreciation and impairment
At 01 May 241,8701,870
Charge for year451451
At 30 April 252,3212,321
Net book value
At 30 April 252,5572,557
At 30 April 243,0083,008
4.Debtors: amounts due within one year

2025

2024

££
Other debtors-651
Prepayments and accrued income303173
Total303824
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables-1,041
Bank borrowings and overdrafts2,1302,028
Taxation and social security2,9342,775
Other creditors6,334-
Total11,3985,844
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts8762,976
Total8762,976